跳至主要内容
临床试验/JPRN-UMIN000024321
JPRN-UMIN000024321已完成未知

Dose inidividualization of antimicrobials based on population pharmacokinetic analysis in patients undergoing blood purification therapy - Dose inidividualization of antimicrobials based on population pharmacokinetic analysis in patients undergoing blood purification therapy

Kumamoto University Hospital0 个研究点目标入组 40 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

In vancomycin-administered-patients with continuous blood purification therapy, we identified reduced urine output (RUO, <0.5 ml/kg/h) and effluent flow rate were the factor for the vancomycin clearance. Using the pharmacokinetic model, The compliance rate for therapeutic trough concentration by the Bayesian estimation was higher (87.0%) than that by a conventional method (53.8%, P = 0.046). The variance was lower (11.5) by the Bayesian estimation than by a conventional method (50.5, P = 0.003).

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 150years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • In state with impossible sampling of blood for measurement of blood antimicrobial concentration

研究者

相似试验